Imagine it is 2030. Doctors in a regional hospital in country X note an expanding cluster of individuals with severe respiratory disease. Rapid whole-genome sequencing identifies the disease-causing agent as a novel coronavirus.
Epidemiological investigations suggest the virus is highly infectious, with most initial cases requiring hospitalisation. The episode bears a striking resemblance to the COVID outbreak first detected in December 2019.
Regional and national health authorities are notified quickly. The national contact point for the International Health Regulations 2024 (a major revision to the current IHR 2005) sends a description to the World Health Organization (WHO). After an intense exchange of information and risk assessment, it declares a public health emergency of international concern.
The outbreak is assigned a response strategy of “elimination”. This designation initiates a well-rehearsed procedure, including mobilising expertise and resource stockpiles.
The elimination response results in localised quarantine measures at the epicentre and its surrounds and a travel freeze across a wide radius within country X and at its borders. It also prompts intensified local and international surveillance. Case numbers rise rapidly but plateau after three weeks, and then fall until no new cases are detected in the community.
After eight weeks of intensive efforts the outbreak is over – similar to the experience of New Zealand, which terminated its initial COVID outbreak in eight weeks using an elimination strategy. The outbreak had spread regionally within country X, but not internationally.
This is how we propose, in The Lancet, the world should respond to future pandemic threats.
An upgraded pandemic response to eliminate at source
The process by which the WHO currently decides whether to declare a public health emergency of international concern (under the International Health Regulations 2005) has drawn criticism for being too slow.
The upgraded response framework we propose would enhance the existing risk assessment by routinely requiring WHO to assign a high-level response strategy for managing this risk. For potential pandemics, we consider this strategy should be elimination rather than suppression or mitigation, which have been the usual default options in the past. In simple terms, “if in doubt, stamp it out.”
The idea of eliminating novel emerging infectious diseases at the earliest possible stage is intuitively appealing and not new. It has been proposed for eliminating novel pandemic influenza outbreaks.
This approach successfully eliminated and then eradicated the SARS pandemic in 2003 (caused by SARS-CoV). It also proved successful in China during early containment of COVID in Wuhan.
We have described this concept previously. Whether this approach could have eliminated and ultimately eradicated COVID, if pursued early and in a co-ordinated way globally, remains a topic of speculation.
An elimination strategy also slows the spread of infection
There is a second broad reason for the WHO assigning an explicit strategic goal of elimination to pandemic diseases with sufficient severity. It can also slow or interrupt the global spread of a new infectious disease. This action buys time for interventions to be developed, building on rapidly accumulating scientific knowledge.
Some countries in the Asia-Pacific region adopted elimination and strong suppression strategies. This approach largely prevented widespread COVID circulation for the first one to two years of the pandemic, keeping mortality rates low.
It allowed time for vaccine development and roll-out and for jurisdictions to prepare their health systems for managing large numbers of infected people. Notable examples are New Zealand, Australia and Singapore. They have been able to keep their cumulative mortality low by international standards.

If elimination is ultimately not successful or justifiable, an organised transition to another strategy (suppression or mitigation) should be considered. Processes for managing these transitions can draw on experience from the current pandemic.
Elimination makes sense for other potential pandemics
The most recently declared public health emergency of international concern is mpox (formerly known as monkeypox). Under our proposed change to the International Health Regulations, the WHO would have been required to assign a response strategy to this disease.
Elimination again makes sense as a default approach. That is what countries around the world have effectively been doing. And this approach appears to be working.
The other current public health emergency of international concern is poliomyelitis. Unlike COVID and mpox, this disease is already subject to a global eradication goal.
A further benefit of the elimination strategy is that it supports strengthening of health system infrastructure in low and middle-income countries. This capacity building has contributed to the elimination of periodic Ebola outbreaks in Africa, which have been designated as public health emergencies of international concern in 2014-16 and 2019-20. It could also support elimination of mpox, an increasing threat in Africa.
Upgraded International Health Regulations could stimulate a huge global investment in infrastructure to stop epidemics at source and improve surveillance capacity. These capacities are critical given the range of future pandemic scenarios, including the threat from bioweapons with advances in synthetic biology.
Let us hope that when the world is next confronted by the spark of a new emerging infectious disease with pandemic potential, the WHO rapidly declares a public health emergency of international concern and assigns an elimination strategy. And the international community reacts vigorously to extinguish the spark before it becomes an inferno.
News
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]















